Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh

Clinical and Vaccine Immunology

Volumn 19, Issue 6, 2012, Pages 842-848

  Patel, Sweta M ^a   Rahman, Mohammad Arif ^a   Mohasin, M ^a   Riyadh, M Asrafuzzaman ^a   Leung, Daniel T ^b,c   Alam, Mohammad Murshid ^a   Chowdhury, Fahima ^a   Khan, Ashraful I ^a   Weil, Ana A ^a,c   Aktar, Amena ^a   Nazim, Mohammad ^a   LaRocque, Regina C ^b,c   Ryan, Edward T ^b,c,d   Calderwood, Stephen B ^b,c   Qadri, Firdausi ^a   Harris, Jason B ^b,c  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHOLERA TOXIN B SUBUNIT; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BANGLADESH; CHOLERA; CONTROLLED STUDY; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIBRIO CHOLERAE;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; B-LYMPHOCYTES; BANGLADESH; CHILD; CHOLERA; CHOLERA TOXIN; FAMILY CHARACTERISTICS; FAMILY HEALTH; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; LIPOPOLYSACCHARIDES; MALE; VIBRIO CHOLERAE O1; YOUNG ADULT;

EID: 84861730297     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00037-12     Document Type: Article

References (31)

1. Alam MM, et al. 2011. Antigen-specific memory B-cell responses in Bangladeshi adults after one or two dose oral killed cholera vaccination, and comparison with responses following natural cholera. Clin. Vaccine Immunol. 18:844-850.
2. Ali M, Emch M, Park JK, Yunus M, Clemens J. 2011. Natural cholera infection-derived immunity in an endemic setting. J. Infect. Dis. 204:912-918.
3. Anonymous. 2010. Cholera vaccines: WHO position paper. Wkly. Epidemiol. Rec. 85:117-128.
4. Cassel D, Selinger Z. 1977. Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site. Proc. Natl. Acad. Sci. U. S. A. 74:3307-3311. (Pubitemid 8177765)
5. Chowdhury F, et al. 2011. Impact of rapid urbanization on the rates of infection by Vibrio cholerae O1 and enterotoxigenic Escherichia coli in Dhaka, Bangladesh. PLoS Negl. Trop. Dis. 5:e999. doi:10.1371/journal.pntd.0000999.
6. Clemens JD, et al. 1990. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 335:270-273. (Pubitemid 20047723)
7. Crotty S, Aubert RD, Glidewell J, Ahmed R. 2004. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods. 286:111-122. (Pubitemid 38490401)
8. Glass RI, et al. 1985. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. J. Infect. Dis. 151:236-242. (Pubitemid 15162711)
9. Harris AM, et al. 2009. Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect. Immun. 77:3850-3856.
10. Harris JB, et al. 2010. Cholera's western front. Lancet. 376:1961-1965.
11. Harris JB, et al. 2008. Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl Trop. Dis. 2:e221. doi:10.1371/journal.pntd.0000221.
12. Harris JB, et al. 2009. Immunologic responses to Vibrio cholerae in patients co-infected with intestinal parasites in Bangladesh. PLoS Negl. Trop. Dis. 3:e403. doi:10.1371/journal.pntd.0000403.
13. Kelly DF, Pollard AJ, Moxon ER. 2005. Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens. JAMA 294:3019-3023. (Pubitemid 41817664)
14. Khan AI, et al. 2010. Comparison of clinical features and immunological parameters of patients with dehydrating diarrhoea infected with Inaba or Ogawa serotypes of Vibrio cholerae O1. Scand. J. Infect. Dis. 42:48-56.
15. Koelle K, Rodo X, Pascual M, Yunus M, Mostafa G. 2005. Refractory periods and climate forcing in cholera dynamics. Nature 436:696-700. (Pubitemid 41117271)
16. Leung DT, et al. 2011. A comparison of memory B cell, antibody secreting cell, and plasma antibody responses in young children, older children, and adults with infection caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh. Clin. Vaccine Immunol. 18:1317-1325.
17. Levine MM, et al. 1981. Duration of infection-derived immunity to cholera. J. Infect. Dis. 143:818-820. (Pubitemid 11062231)
18. Mintz ED, Guerrant RL. 2009. A lion in our village-the unconscionable tragedy of cholera in Africa. N. Engl. J. Med. 360:1060-1063.
19. Mosley WH, Ahmad S, Benenson AS, Ahmed A. 1968. The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients. Bull. World Health Organ. 38:777-785.
20. Nelson EJ, Harris JB, Morris JG, Jr, Calderwood SB, Camilli A. 2009. Cholera transmission: the host, pathogen and bacteriophage dynamic. Nat. Rev. Microbiol. 7:693-702.
21. Neoh SH, Rowley D. 1970. The antigens of Vibrio cholerae involved in the vibriocidal action of antibody and complement. J. Infect. Dis. 121:505-513.
22. Qadri F, et al. 1999. Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera. Clin. Diagn. Lab. Immunol. 6:812-818. (Pubitemid 29529971)
23. Qadri F, et al. 1997. Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. Infect. Immun. 65:3571-3576. (Pubitemid 27398109)
24. Ryan ET, et al. 2000. Mortality, morbidity, and microbiology of endemic cholera among hospitalized patients in Dhaka, Bangladesh. Am. J. Trop. Med. Hyg. 63:12-20. (Pubitemid 32423089)
25. Saha D, et al. 2004. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh. J. Infect. Dis. 189:2318-2322. (Pubitemid 38757206)
26. Sharp GW, Hynie S. 1971. Stimulation of intestinal adenyl cyclase by cholera toxin. Nature 229:266-269.
27. Tamayo JF, et al. 1965. Studies of cholera El Tor in the Philippines. 3. Transmission of infection among household contacts of cholera patients. Bull. World Health Organ. 33:645-649.
28. Uddin T, et al. 2011. Mucosal immunologic responses in cholera patients in Bangladesh. Clin. Vaccine Immunol. 18:506-512.
29. Weil AA, et al. 2009. Clinical outcomes in household contacts of patients with cholera in Bangladesh. Clin. Infect. Dis. 49:1473-1479.
30. WHO. 2003. Cholera unveiled. WHO, Geneva, Switzerland. http://whqlibdoc.who.int/hq/2003/WHO-CDS-CPE-ZFK-2003.3.pdf.
31. Zuckerman JN, Rombo L, Fisch A. 2007. The true burden and risk of cholera: implications for prevention and control. Lancet Infect. Dis. 7:521-530. (Pubitemid 47079151)